Trial Profile
A Pivotal Bioequivalence Study of 250 Mcg NGM/25 Mcg EE [ethinylestradiol/norgestimate] With or Without Folic Acid in Healthy Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/norgestimate (Primary) ; Folic acid
- Indications Menopausal syndrome; Pregnancy
- Focus Pharmacokinetics; Registrational
- Sponsors Janssen Research & Development
- 28 Jul 2008 New trial record.